Morphosys Aktie News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys aktie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Aktie Today - Breaking & Trending Today

MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study Seite 1

11.12.2023 - MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-naïve . Seite 1 ....

Raajitk Rampal , Myeloproliferative Neoplasms Program , Memorial Sloan Kettering Cancer Center , Hematologic Malignancies , Memorial Sloan , Kettering Cancer , Morphosys Aktie ,

Ad hoc: MorphoSys' Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction

20.11.2023 - Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014MANIFEST-2 met primary endpoint, nearly doubling SVR35 response rate (66% versus 35%)The key secondary endpoints assessing symptom reduction, . Seite 1 ....

Dynamic International Prognostic Scoring System , Spleen Volume , Morphosys Chart , Orphosys Kurs , Morphosys Aktie ,